INmune Bio Ownership | Who Owns INmune Bio?


OverviewForecastFinancialsChartTranscripts

INmune Bio Ownership Summary


INmune Bio is owned by 13.06% institutional investors, 11.17% insiders, and 75.77% retail investors. Blackrock is the largest institutional shareholder, holding 4.51% of INMB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.91% of its assets in INmune Bio shares.

INMB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockINmune Bio13.06%11.17%75.77%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock812.89K4.51%$7.17M
Blackrock funding, inc. /de1.19M4.49%$1.35M
Vanguard group957.85K3.60%$1.49M
Cvi596.37K3.31%$5.26M
Geode capital management494.97K1.86%$559.46K
Millennium management291.33K1.44%$1.36M
Raymond james financial services advisors227.53K1.26%$2.01M
State street290.88K1.09%$328.69K
Aqr capital management270.32K1.02%$305.46K
Ubs group253.34K0.95%$286.27K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cvi596.37K4.54%$5.26M
Dauntless investment group183.48K0.14%$207.33K
Westside investment management108.30K0.02%$122.38K
Eversource wealth advisors3.36K0.01%$426.04K
Raymond james financial services advisors227.53K0.00%$2.01M
Two sigma securities14.53K0.00%$16.42K
Laird norton trust company50.00K0.00%$56.50K
Millennium management291.33K0.00%$1.36M
Xtx topco30.31K0.00%$34.25K
Buckingham strategic partners43.02K0.00%$48.62K

Top Buyers

HolderShares% AssetsChange
Cvi596.37K4.54%596.37K
Blackrock812.89K0.00%572.73K
Aqr capital management270.32K0.00%249.80K
Raymond james financial services advisors227.53K0.00%227.53K
Ubs group253.34K-192.54K

Top Sellers

HolderShares% AssetsChange
Praetorian pr---865.00K
Rhenman & partners asset management ab---178.28K
Dauntless investment group183.48K0.14%-121.45K
Pekin hardy strauss---94.30K
National bank of canada /fi/200.00--92.10K

New Positions

HolderShares% AssetsChangeValue
Cvi596.37K4.54%596.37K$5.26M
Raymond james financial services advisors227.53K0.00%227.53K$2.01M
Vanguard fiduciary trust123.18K-123.18K$139.20K
Ieq capital24.56K0.00%24.56K$27.76K
Renaissance17.00K-17.00K$19.21K

Sold Out

HolderChange
Steward partners investment advisory-5.00
Skopos labs-90.00
Fny investment advisers-100.00
Thurston, springer, miller, herd & titak-106.00
Coldstream capital management-145.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202651-32.89%3,473,326-31.69%133.57%26-23.53%12-45.45%
Dec 31, 202555-31.25%4,087,962-12.20%153.85%22-42.11%16-30.43%
Sep 30, 202578-12.36%4,653,472-15.00%193.62%37-33.93%2376.92%
Jun 30, 20259510.47%5,614,076-5.01%243.49%5947.50%14-39.13%
Mar 31, 20258716.00%5,927,552-3.93%262.82%41-14.58%23228.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF434.27K1.91%-
Vanguard Total Stock Mkt Idx Inv490.27K1.84%-
iShares Russell 2000 ETF401.59K1.51%3.38K
Fidelity Small Cap Index203.89K0.77%-826.00
iShares Russell 2000 Growth ETF201.97K0.76%520.00
Vanguard Institutional Extnd Mkt Idx Tr196.75K0.74%-
Rhenman Healthcare Equity L/S RC2 SEK178.28K0.67%-
Bridge Builder Tax Managed Sm/Md Cp164.97K0.61%164.97K
Fidelity Extended Market Index138.57K0.52%33.84K
Vanguard Russell 2000 ETF112.42K0.42%2.34K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 30, 2024Moss David J Chief Financial OfficerBuy$52.87K
Sep 12, 2024Tesi Raymond Joseph President and CEOBuy$98.43K
Sep 12, 2024Tesi Raymond Joseph President and CEOBuy$98.05K
Sep 12, 2024Moss David J Chief Financial OfficerBuy$49.22K
Sep 12, 2024Moss David J Chief Financial OfficerBuy$49.02K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2024 Q4--
2024 Q35-
2024 Q29-

INMB Ownership FAQ


Who Owns INmune Bio?

INmune Bio shareholders are primarily institutional investors at 13.06%, followed by 11.17% insiders and 75.77% retail investors. The average institutional ownership in INmune Bio's industry, Biotech Stocks , is 35.75%, which INmune Bio falls below.

Who owns the most shares of INmune Bio?

INmune Bio’s largest shareholders are Blackrock (812.9K shares, 4.51%), Blackrock funding, inc. /de (1.19M shares, 4.49%), and Vanguard group (957.85K shares, 3.60%). Together, they hold 12.60% of INmune Bio’s total shares outstanding.

Does Blackrock own INmune Bio?

Yes, BlackRock owns 4.51% of INmune Bio, totaling 812.9K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.17M$. In the last quarter, BlackRock increased its holdings by 572.73K shares, a 238.47% change.

Who is INmune Bio’s biggest shareholder by percentage of total assets invested?

Cvi is INmune Bio’s biggest shareholder by percentage of total assets invested, with 4.54% of its assets in 596.37K INmune Bio shares, valued at 5.26M$.

Who is the top mutual fund holder of INmune Bio shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of INmune Bio shares, with 1.91% of its total shares outstanding invested in 434.27K INmune Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools